Evidence map›Paper›PMID 38234777›Full record

ArticlebioRxiv : the preprint server for biology2024

Gene Network Analyses Identify Co-regulated Transcription Factors and BACH1 as a Key Driver in Rheumatoid Arthritis Fibroblast-like Synoviocytes.

Aurelien Pelissier, Teresina Laragione, Carolyn Harris, María Rodríguez Martínez, Percio S Gulko

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 3 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 2 countries.

Aurelien PelissierIBM Research Europe, 8803 Ruschlikon, Switzerland.ORCID 0000-0001-6638-5829
Teresina LaragioneDivision of Rheumatology, Icahn School of Medicine at Mount Sinai, 10029 New York, United States.
Carolyn HarrisDivision of Rheumatology, Icahn School of Medicine at Mount Sinai, 10029 New York, United States.
María Rodríguez MartínezIBM Research Europe, 8803 Ruschlikon, Switzerland.
Percio S GulkoDivision of Rheumatology, Icahn School of Medicine at Mount Sinai, 10029 New York, United States.
Icahn School of Medicine at Mount Sinai · USYale University · USZHAW Zurich University of Applied Sciences · CH

Funding

Magnesium and Arthritis PathogenesisR01AR073165 · NIAMS · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI GULKO, PERCIO S · 2019 to 2023
$1.8M
NIAMS NIH HHS R01 AR073165
6 · The paper itself

Abstract

RNA-sequencing and differential gene expression studies have significantly advanced our understanding of pathogenic pathways underlying Rheumatoid Arthritis (RA). Yet, little is known about cell-specific regulatory networks and their contributions to disease. In this study, we focused on fibroblast-like synoviocytes (FLS), a cell type central to disease pathogenesis and joint damage in RA. We used a strategy that computed sample-specific gene regulatory networks (GRNs) to compare network properties between RA and osteoarthritis FLS. We identified 28 transcription factors (TFs) as key regulators central to the signatures of RA FLS. Six of these TFs are new and have not been previously implicated in RA, and included BACH1, HLX, and TGIF1. Several of these TFs were found to be co-regulated, and BACH1 emerged as the most significant TF and regulator. The main BACH1 targets included those implicated in fatty acid metabolism and ferroptosis. The discovery of BACH1 was validated in experiments with RA FLS. Knockdown of BACH1 in RA FLS significantly affected the gene expression signatures, reduced cell adhesion and mobility, interfered with the formation of thick actin fibers, and prevented the polarized formation of lamellipodia, all required for the RA destructive behavior of FLS. This is the first time that BACH1 is shown to have a central role in the regulation of FLS phenotypes, and gene expression signatures, as well as in ferroptosis and fatty acid metabolism. These new discoveries have the potential to become new targets for treatments aimed at selectively targeting the RA FLS.

Identifiers

PMID38234777
PMCPMC10793426
OpenAlexW4390336576

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.